{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:28:04Z","timestamp":1791678484744,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12 CA167540"],"award-info":[{"award-number":["K12 CA167540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009340","name":"Children's Discovery Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018235","name":"St Louis Children's Hospital","doi-asserted-by":"publisher","award":["FDN-2023-122"],"award-info":[{"award-number":["FDN-2023-122"]}],"id":[{"id":"10.13039\/100018235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtct.2025.09.025","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:01:27Z","timestamp":1758081687000},"page":"82.e1-82.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Excellent Outcomes in Feasibility Study of Radiation-Free Conditioning and Transplant in Pediatric Severe Aplastic Anemia"],"prefix":"10.1016","volume":"32","author":[{"given":"Mithra Lakshmi","family":"Narasimhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9930-7990","authenticated-orcid":false,"given":"Irem","family":"Eldem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-0876","authenticated-orcid":false,"given":"Jeffrey J.","family":"Bednarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-5268","authenticated-orcid":false,"given":"Ginny L.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-1139","authenticated-orcid":false,"given":"Robert J.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2025.09.025_bib0001","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.12855","article-title":"The epidemiology of acquired aplastic anemia","volume":"93","author":"Young","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2141.2012.09058.x","article-title":"How I manage aplastic anaemia in children","volume":"157","author":"Samarasinghe","year":"2012","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.025_bib0003","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM198203253061204","article-title":"Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis","volume":"306","author":"Camitta","year":"1982","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.025_bib0004","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat acquired aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2012.09130.x","article-title":"Success of allogeneic marrow transplantation for children with severe aplastic anaemia","volume":"158","author":"Burroughs","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/bbmt.2001.v7.pm11215697","article-title":"Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers","volume":"7","author":"Storb","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.025_bib0007","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.025_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2141.2007.06903.x","article-title":"Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up","volume":"140","author":"Saracco","year":"2008","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.jtct.2025.09.025_bib0009","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","article-title":"Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome","volume":"124","author":"Kulasekararaj","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.025_bib0011","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.1993.tb03181.x","article-title":"Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party","volume":"85","author":"Schrezenmeier","year":"1993","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.025_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28444","volume":"67","author":"Pulsipher","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.025_bib0013","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2018.04.001","article-title":"Haploidentical donor bone marrow transplantation for severe aplastic anemia","volume":"32","author":"DeZern","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"10.1016\/j.jtct.2025.09.025_bib0014","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3026(22)00206-X","article-title":"Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial","volume":"9","author":"DeZern","year":"2022","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.025_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2014.115345","article-title":"Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis","volume":"100","author":"Bacigalupo","year":"2015","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.025_bib0016","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.13614","volume":"171","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.jtct.2025.09.025_bib0017","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2011-05-354001","article-title":"Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia","volume":"118","author":"Eapen","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.025_bib0018","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbmt.2016.02.001","article-title":"Alternative-donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for nonmalignant disorders","volume":"22","author":"Klein","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.025_bib0019","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jtct.2024.09.017","article-title":"Allogeneic hematopoietic cell transplantation for the treatment of severe aplastic anemia: evidence-based guidelines from the American Society for Transplantation and Cellular Therapy","volume":"30","author":"Iftikhar","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V87.1.386.386","article-title":"Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients","volume":"87","author":"Deeg","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(22)00655-6","article-title":"Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study","volume":"24","author":"Hauptmann","year":"2023","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.025_bib0034","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/s41591-023-02620-0","article-title":"Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults","volume":"29","author":"Bosch de Basea","year":"2023","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.jtct.2025.09.025_bib0023","first-page":"3894","article-title":"Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease","volume":"4","author":"Ngwube","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.025_bib0022","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.25458","article-title":"Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia","volume":"62","author":"Ngwube","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.025_bib0024","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.bbmt.2015.03.019","article-title":"Hematopoietic cell transplantation using reduced-intensity conditioning is successful in children with hematologic cytopenias of genetic origin","volume":"21","author":"Kothari","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.025_bib0025","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.025_bib0026","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.025_bib0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1191\/1740774505cn078oa","article-title":"Translational clinical trials: an entropy-based approach to sample size","volume":"2","author":"Piantadosi","year":"2005","journal-title":"Clin Trials"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.025_bib0028","doi-asserted-by":"crossref","first-page":"534.e1","DOI":"10.1016\/j.jtct.2024.02.002","article-title":"Fertility potential and gonadal function in survivors of reduced-intensity hematopoietic stem cell transplantation","volume":"30","author":"Rotz","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.025_bib0029","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/pbc.25102","article-title":"Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease","volume":"61","author":"Williams","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.025_bib0030","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.bbmt.2020.06.027","article-title":"Fludarabine, campath, and low-dose cyclophosphamide (FCC(low)) with or without TBI conditioning results in excellent transplant outcomes in children with severe aplastic anemia","volume":"26","author":"Shah","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.025_bib0031","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41409-020-0948-8","article-title":"Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine\/melphalan vs. fludarabine\/cyclophosphamide","volume":"55","author":"Yoshida","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.025_bib0032","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12185-021-03254-z","article-title":"Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children","volume":"115","author":"Sawada","year":"2022","journal-title":"Int J Hematol"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.025_bib0035","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1200\/JCO.22.01203","article-title":"Secondary neoplasms after hematopoietic cell transplant for sickle cell disease","volume":"41","author":"Eapen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.025_bib0036","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/bloodadvances.2022008545","article-title":"Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure","volume":"7","author":"Stenger","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.09.025_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.06.015","article-title":"Impact of abatacept inclusive graft versus host disease prophylaxis in pediatric stem cell transplantation for hemoglobinopathy","author":"Shah","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.025_bib0038","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3324\/haematol.2014.106096","article-title":"Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"99","author":"Dufour","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.025_bib0039","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjh.13297","article-title":"Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant","volume":"169","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/bmt.2013.115","article-title":"Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation","volume":"49","author":"Marsh","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.025_bib0041","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2024024173","article-title":"Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT","volume":"144","author":"Montoro","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.025_bib0042","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.hoc.2018.03.002","article-title":"Somatic mutations in aplastic anemia","volume":"32","author":"Mufti","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.025_bib0043","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12015-020-09971-y","article-title":"Acquired aplastic anemia as a clonal disorder of hematopoietic stem cells","volume":"16","author":"Brze\u017aniakiewicz-Janus","year":"2020","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.025_bib0044","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5045\/br.2020.2020012","article-title":"An interesting story of a clone","volume":"55","author":"Juneja","year":"2020","journal-title":"Blood Res"},{"issue":"15","key":"10.1016\/j.jtct.2025.09.025_bib0045","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1182\/bloodadvances.2023011642","article-title":"Modified Delphi panel consensus recommendations for management of severe aplastic anemia","volume":"8","author":"Babushok","year":"2024","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.025_bib0046","doi-asserted-by":"crossref","first-page":"105.e1","DOI":"10.1016\/j.jtct.2021.10.006","volume":"28","author":"Alotaibi","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.025_bib0047","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/petr.12073","article-title":"Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia","volume":"17","author":"Chung","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.025_bib0048","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.jtct.2025.09.025_bib0049","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.bbmt.2012.05.006","article-title":"Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution","volume":"18","author":"Law","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.025_bib0050","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1704235","article-title":"Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients","volume":"32","author":"Fallen","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.025_bib0051","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbmt.2018.10.008","article-title":"Immune reconstitution and infection patterns after early alemtuzumab and reduced intensity transplantation for nonmalignant disorders in pediatric patients","volume":"25","author":"Bhatt","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.025_bib0052","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.025_bib0053","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","article-title":"Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation","volume":"87","author":"Sanders","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.025_bib0054","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","article-title":"Long-term outcome after marrow transplantation for severe aplastic anemia","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.025_bib0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.2000.02452.x","article-title":"Late outcomes after bone marrow transplant for aplastic anaemia","volume":"111","author":"Eapen","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0056","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V87.1.386.386","article-title":"Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients","volume":"87","author":"Deeg","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0057","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000041004","article-title":"Cure from severe aplastic anemia in vivo and late effects","volume":"103","author":"Socie","year":"2000","journal-title":"Acta Haematol"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.025_bib0058","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S2352-4642(24)00167-6","article-title":"Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study","volume":"8","author":"Kahn","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0059","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/ehm.10.81","article-title":"Iron overload and allogeneic hematopoietic stem-cell transplantation","volume":"4","author":"Kanda","year":"2011","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2002.03527.x","article-title":"Endocrine late effects after bone marrow transplant","volume":"118","author":"Brennan","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.025_bib0061","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2011.10.007","article-title":"Bone loss and avascular necrosis of bone after hematopoietic cell transplantation","volume":"49","author":"McClune","year":"2012","journal-title":"Semin Hematol"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.025_bib0062","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1200\/JCO.1997.15.6.2238","article-title":"Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation\u2013a report from the Societe Francaise de Greffe de Moelle","volume":"15","author":"Michel","year":"1997","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.025_bib0063","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajh.22247","article-title":"Pituitary iron and volume predict hypogonadism in transfusional iron overload","volume":"87","author":"Noetzli","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2025.09.025_bib0021","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood-2024-206543","article-title":"Successful allogenic stem cell transplantation using radiation-free reduced intensity conditioning in idiopathic pediatric severe aplastic anemia-a single center experience","volume":"144","author":"Narasimhan","year":"2024","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T02:59:01Z","timestamp":1772938741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725014496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666636725014496"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.025","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excellent Outcomes in Feasibility Study of Radiation-Free Conditioning and Transplant in Pediatric Severe Aplastic Anemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}